Access cutting-edge pediatric sepsis treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access pediatric sepsis specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pediatric sepsis treatment provided free
The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).
Sponsor: Nationwide Children's Hospital
Check if you qualify for this pediatric sepsis clinical trial in Los Angeles, CA
If you're searching for pediatric sepsis treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric sepsis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.